UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Detection and monitoring of ovarian cancer

Clinica chimica acta, 2013-01, Vol.415, p.341-345

2013

Volltextzugriff (PDF)

Impact of smoking on perioperative pulmonary and upper respiratory complications after laparoscopic gynecologic surgery

Gynecologic oncology, 2012-06, Vol.125 (3), p.556-560

2012

Volltextzugriff (PDF)

Racial disparities in treatment and survival from ovarian cancer

Cancer epidemiology, 2019-02, Vol.58, p.77-82

2019

Volltextzugriff (PDF)

Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial

Gynecologic oncology, 2024-08, Vol.187, p.128-138

2024

Volltextzugriff (PDF)

Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions

International journal of gynecological cancer, 2023-11, Vol.33 (11), p.1733-1742

2023

Volltextzugriff (PDF)

Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study

International journal of gynecological cancer, 2024-07, Vol.34 (7), p.1041-1050

2024

Volltextzugriff (PDF)

Morbidity and mortality of vulvar and vaginal cancers: Impact of 2-, 4-, and 9-valent HPV vaccines

Human vaccines & immunotherapeutics, 2016-06, Vol.12 (6), p.1352-1356

2016

Volltextzugriff (PDF)

Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma

Gynecologic oncology, 2017-07, Vol.146 (1), p.11-15

2017

Volltextzugriff (PDF)

Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer

Clinical cancer research, 2015-01, Vol.21 (2), p.448-459

2015

Volltextzugriff (PDF)

A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial

Future oncology (London, England), 2024-04, Vol.20 (13), p.799-809

2024

Volltextzugriff (PDF)

Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases?

Gynecologic oncology, 2016-08, Vol.142 (2), p.278-282

2016

Volltextzugriff (PDF)

Vintafolide: a novel targeted agent for epithelial ovarian cancer

Future oncology (London, England), 2014-03, Vol.10 (4), p.541-548

2014

Volltextzugriff (PDF)

Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial

The lancet. Gastroenterology & hepatology, 2023-10, Vol.8 (10), p.908-918

2023

Volltextzugriff (PDF)

Silencing of p130Cas in Ovarian Carcinoma: A Novel Mechanism for Tumor Cell Death

JNCI : Journal of the National Cancer Institute, 2011-11, Vol.103 (21), p.1596-1612

2011

Volltextzugriff (PDF)

Vaginal cancer: the experience from 2 large academic centers during a 15-year period

Journal of lower genital tract disease, 2013-10, Vol.17 (4), p.409-413

2013

Volltextzugriff (PDF)

EP233/#541 Patterns of initial ovarian cancer recurrence on niraparib maintenance monotherapy in patients with no baseline evidence of disease following first-line chemotherapy: PRIMA/ENGOT-ov26/GOG-3012 post-hoc subgroup analysis

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A144-A144

2022

Volltextzugriff (PDF)

EP224/#531 Optimization of assessment of disease progression between blinded central independent review and investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A140-A141

2022

Volltextzugriff (PDF)

Small bowel perforation 17 months after robotic surgery for endometrial cancer: A case report

Gynecologic oncology case reports, 2011, Vol.2 (1), p.9-10

2011

Volltextzugriff (PDF)

Tumor proximity to serosal surface as an independent prognostic factor in FIGO stage 1 endometrial cancer

European journal of gynaecological oncology, 2021-06, Vol.42 (3), p.574

2021

Volltextzugriff (PDF)

Small bowel perforation 17months after robotic surgery for endometrial cancer: A case report

Gynecologic oncology case reports, 2012-01, Vol.2 (1), p.9-10

2012

Volltextzugriff (PDF)

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

The New England journal of medicine, 2019-12, Vol.381 (25), p.2391-2402

2019

Volltextzugriff (PDF)

Association of Serum Thyroxine and Atrial Fibrillation in Patients on Levothyroxine

Military medicine, 2024-06

2024

Volltextzugriff (PDF)

Role of adjuvant therapy for early-stage squamous cell carcinoma of the endometrium (1174)

Gynecologic oncology, 2023-09, Vol.176, p.S120-S121

2023

Volltextzugriff (PDF)

Current practices using pembrolizumab and lenvatinib for advanced uterine cancer at a high-volume gynecologic oncology referral center in the Southeast (2116)

Gynecologic oncology, 2023-09, Vol.176, p.S206-S207

2023

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(45)
Berichte
(1)

Sprache

Englisch
(46)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Oncology
(21)
Ovarian Cancer
(21)
Female
(20)
Humans
(20)
Obstetrics & Gynecology
(14)
Chemotherapy
(9)
Ovarian Neoplasms - Drug Therapy
(9)
Adult
(7)
Middle Aged
(7)
Niraparib
(7)
Obstetrics And Gynecology
(7)
Cancer Therapies
(6)
Hematology, Oncology And Palliative Medicine
(6)
Parp Inhibitor
(6)
Patients
(6)
Tumors
(6)
Aged
(5)
Aged, 80 And Over
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Detection and monitoring of ovarian cancer

Impact of smoking on perioperative pulmonary and upper respiratory complications after laparoscopic gynecologic surgery

Racial disparities in treatment and survival from ovarian cancer

Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial

Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial

Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions

Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study

Morbidity and mortality of vulvar and vaginal cancers: Impact of 2-, 4-, and 9-valent HPV vaccines

Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma

Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer

A plain language summary of publication of the efficacy and safety of individualized niraparib dosing based on baseline body weight and platelet count in the PRIMA/ENGOT-OV26/GOG-3012 trial

Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases?

Vintafolide: a novel targeted agent for epithelial ovarian cancer

Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial

Silencing of p130Cas in Ovarian Carcinoma: A Novel Mechanism for Tumor Cell Death

Vaginal cancer: the experience from 2 large academic centers during a 15-year period

EP233/#541 Patterns of initial ovarian cancer recurrence on niraparib maintenance monotherapy in patients with no baseline evidence of disease following first-line chemotherapy: PRIMA/ENGOT-ov26/GOG-3012 post-hoc subgroup analysis

EP224/#531 Optimization of assessment of disease progression between blinded central independent review and investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial

Small bowel perforation 17 months after robotic surgery for endometrial cancer: A case report

Tumor proximity to serosal surface as an independent prognostic factor in FIGO stage 1 endometrial cancer

Small bowel perforation 17months after robotic surgery for endometrial cancer: A case report

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Association of Serum Thyroxine and Atrial Fibrillation in Patients on Levothyroxine

Role of adjuvant therapy for early-stage squamous cell carcinoma of the endometrium (1174)

Current practices using pembrolizumab and lenvatinib for advanced uterine cancer at a high-volume gynecologic oncology referral center in the Southeast (2116)

Suchergebnisse filtern